Biovotion ramps up manufacturing

Swiss digital medicine company Biovotion announces an important step towards a broader commercialisation of its Everion and data analytics solutions. The company received CE regulatory clearance and passed an ISO audit.

Biovotion develops a medical grade vital sign monitoring platform. The company is now ramping up manufacturing to serve first pilot customers. After having received CE regulatory clearance for the Vital Sign Monitor as a class 2a medical device end of last year, Biovotion recently also passed the annual ISO 13485 surveillance audit for the company and the manufacturing and supply chain.
“This is another important step towards a broader commercialisation of Biovotion’s Everion and data analytics solutions in an evolving regulatory environment”, writes biovotion in a blog post.The next milestone is the first FDA registration to also fully serve the US market.

Biovotion Everion

Biovotion Ltd is a leading wearable physiology monitoring company and provides integrated solutions with connected hardware and value-added monitoring services. Biovotion Ltd’s digital health solutions support users in keeping a healthy lifestyle, improve healthcare treatment outcomes, and aiming to reduce cost of health provision.

The company is backed by investors such as Swiss Re, STMicroelectronics and Harmony Medical Inc., a Hong-Kong based investment company.